Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bernard E. Ebruke is active.

Publication


Featured researches published by Bernard E. Ebruke.


Lancet Infectious Diseases | 2016

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

Grant Mackenzie; Philip C. Hill; David Jeffries; Ilias Hossain; Uchendu Uchendu; David Ameh; Malick Ndiaye; Oyedeji Adeyemi; Jayani Pathirana; Yekini Olatunji; Bade Abatan; Bilquees S Muhammad; Augustin E. Fombah; Debasish Saha; Ian Plumb; Aliu Akano; Bernard E. Ebruke; Readon C. Ideh; Bankole Kuti; Peter Githua; Emmanuel Olutunde; Ogochukwu Ofordile; Edward Green; Effua Usuf; Henry Badji; Usman N. Ikumapayi; Ahmad Manjang; Rasheed Salaudeen; E David Nsekpong; Sheikh Jarju

Summary Background Little information is available about the effect of pneumococcal conjugate vaccines (PCVs) in low-income countries. We measured the effect of these vaccines on invasive pneumococcal disease in The Gambia where the 7-valent vaccine (PCV7) was introduced in August, 2009, followed by the 13-valent vaccine (PCV13) in May, 2011. Methods We conducted population-based surveillance for invasive pneumococcal disease in individuals aged 2 months and older who were residents of the Basse Health and Demographic Surveillance System (BHDSS) in the Upper River Region, The Gambia, using standardised criteria to identify and investigate patients. Surveillance was done between May, 2008, and December, 2014. We compared the incidence of invasive pneumococcal disease between baseline (May 12, 2008–May 11, 2010) and after the introduction of PCV13 (Jan 1, 2013–Dec 31, 2014), adjusting for changes in case ascertainment over time. Findings We investigated 14 650 patients, in whom we identified 320 cases of invasive pneumococcal disease. Compared with baseline, after the introduction of the PCV programme, the incidence of invasive pneumococcal disease decreased by 55% (95% CI 30–71) in the 2–23 months age group, from 253 to 113 per 100 000 population. This decrease was due to an 82% (95% CI 64–91) reduction in serotypes covered by the PCV13 vaccine. In the 2–4 years age group, the incidence of invasive pneumococcal disease decreased by 56% (95% CI 25–75), from 113 to 49 cases per 100 000, with a 68% (95% CI 39–83) reduction in PCV13 serotypes. The incidence of non-PCV13 serotypes in children aged 2–59 months increased by 47% (−21 to 275) from 28 to 41 per 100 000, with a broad range of serotypes. The incidence of non-pneumococcal bacteraemia varied little over time. Interpretation The Gambian PCV programme reduced the incidence of invasive pneumococcal disease in children aged 2–59 months by around 55%. Further surveillance is needed to ascertain the maximum effect of the vaccine in the 2–4 years and older age groups, and to monitor serotype replacement. Low-income and middle-income countries that introduce PCV13 can expect substantial reductions in invasive pneumococcal disease. Funding GAVIs Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP), Bill & Melinda Gates Foundation, and the UK Medical Research Council.


Clinical Infectious Diseases | 2014

Etiology of Severe Childhood Pneumonia in The Gambia, West Africa, Determined by Conventional and Molecular Microbiological Analyses of Lung and Pleural Aspirate Samples

Stephen R. C. Howie; Gerard A. J. Morris; Rafal Tokarz; Bernard E. Ebruke; Eunice Machuka; Readon C. Ideh; Osaretin Chimah; Ousman Secka; John Townend; Michel M. Dione; Claire Oluwalana; Malick Njie; Mariatou Jallow; Philip C. Hill; Martin Antonio; Brian Greenwood; Thomas Briese; Kim Mulholland; Tumani Corrah; W. Ian Lipkin; Richard A. Adegbola

Molecular analyses of lung aspirates from Gambian children with severe pneumonia detected pathogens more frequently than did culture and showed a predominance of bacteria, principally Streptococcuspneumoniae, >75% being of serotypes covered by current pneumococcal conjugate vaccines. Multiple pathogens were detected frequently, notably Haemophilus influenzae (mostly nontypeable) together with S. pneumoniae.


Clinical Infectious Diseases | 2017

Safety of Induced Sputum Collection in Children Hospitalized With Severe or Very Severe Pneumonia

Andrea N. DeLuca; Laura L. Hammitt; Julia Kim; Melissa M. Higdon; Henry C. Baggett; W. Abdullah Brooks; Stephen R. C. Howie; Maria Deloria Knoll; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Tussanee Amornintapichet; Juliet O. Awori; Somchai Chuananon; Amanda J. Driscoll; Bernard E. Ebruke; Lokman Hossain; Yasmin Jahan; E. Wangeci Kagucia; Sidi Kazungu; David P. Moore; Azwifarwi Mudau; Lawrence Mwananyanda; Daniel E. Park; Christine Prosperi; Phil Seidenberg; Mamadou Sylla

Abstract Background. Induced sputum (IS) may provide diagnostic information about the etiology of pneumonia. The safety of this procedure across a heterogeneous population with severe pneumonia in low- and middle-income countries has not been described. Methods. IS specimens were obtained as part a 7-country study of the etiology of severe and very severe pneumonia in hospitalized children <5 years of age. Rigorous clinical monitoring was done before, during, and after the procedure to record oxygen requirement, oxygen saturation, respiratory rate, consciousness level, and other evidence of clinical deterioration. Criteria for IS contraindications were predefined and serious adverse events (SAEs) were reported to ethics committees and a central safety monitor. Results. A total of 4653 IS procedures were done among 3802 children. Thirteen SAEs were reported in relation to collection of IS, or 0.34% of children with at least 1 IS specimen collected (95% confidence interval, 0.15%–0.53%). A drop in oxygen saturation that required supplemental oxygen was the most common SAE. One child died after feeding was reinitiated 2 hours after undergoing sputum induction; this death was categorized as “possibly related” to the procedure. Conclusions. The overall frequency of SAEs was very low, and the nature of most SAEs was manageable, demonstrating a low-risk safety profile for IS collection even among severely ill children in low-income-country settings. Healthcare providers should monitor oxygen saturation and requirements during and after IS collection, and assess patients prior to reinitiating feeding after the IS procedure, to ensure patient safety.


Clinical Infectious Diseases | 2014

Discovery and Validation of Biomarkers to Guide Clinical Management of Pneumonia in African Children

Honglei Huang; Readon C. Ideh; Evelyn Gitau; Marie L. Thézénas; Muminatou Jallow; Bernard E. Ebruke; Osaretin Chimah; Claire Oluwalana; Henri Karanja; Grant Mackenzie; Richard A. Adegbola; Dominic P. Kwiatkowski; Benedikt M. Kessler; James A. Berkley; Stephen R. C. Howie; Climent Casals-Pascual

Lipocalin 2 distinguishes severe and bacterial pneumonia from nonsevere and nonbacterial pneumonia with a high level of precision. The clinical impact of this biomarker requires large-scale clinical evaluation.


Clinical Infectious Diseases | 2013

The Effectiveness of Conjugate Haemophilus influenzae Type B Vaccine in The Gambia 14 Years After Introduction

Stephen R. C. Howie; Claire Oluwalana; Ousman Secka; Susana Scott; Readon C. Ideh; Bernard E. Ebruke; Anne Balloch; Sana Sambou; James Erskine; Yamundow Lowe; Tumani Corrah; Richard A. Adegbola

Fourteen years after the first introduction of conjugate Haemophilus influenzae type b vaccine in The Gambia, effective disease control was maintained, with associated low carriage and high seroprotection. Continued surveillance must determine if protection wanes and a booster dose is needed.


Journal of Exposure Science and Environmental Epidemiology | 2012

The exposure of infants and children to carbon monoxide from biomass fuels in The Gambia: a measurement and modeling study

Kathie L. Dionisio; Stephen R. C. Howie; Francesca Dominici; Kimberly Fornace; John D. Spengler; Simon Donkor; Osaretin Chimah; Claire Oluwalana; Readon C. Ideh; Bernard E. Ebruke; Richard A. Adegbola; Majid Ezzati

Smoke from biomass fuels is a risk factor for pneumonia, the leading cause of child death worldwide. Although particulate matter (PM) is the metric of choice for studying the health effects of biomass smoke, measuring childrens PM exposure is difficult. Carbon monoxide (CO), which is easier to measure, can be used as a proxy for PM exposure. We measured the exposure of children ≤5 years of age in The Gambia to CO using small, passive, color stain diffusion tubes. We conducted multiple CO measurements on a subset of children to measure day-to-day exposure variability. Usual CO exposure was modeled using a mixed effects model, which also included individual and household level exposure predictors. Mean measured CO exposure for 1181 children (n=2263 measurements) was 1.04±1.46 p.p.m., indicating that the Gambian children in this study on average have a relatively low CO exposure. However, 25% of children had exposures of 1.3 p.p.m. or higher. CO exposure was higher during the rainy months (1.33±1.62 p.p.m.). Burning insect coils, using charcoal, and measurement done in the rainy season were associated with higher exposure. A parsimonious model with fuel, season, and other PM sources as covariates explained 39% of between-child variation in exposure and helped remove within-child variability.


International Journal of Tuberculosis and Lung Disease | 2011

Transthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The Gambia.

Readon C. Ideh; Stephen R. C. Howie; Bernard E. Ebruke; Ousman Secka; Brian Greenwood; Richard A. Adegbola; Tumani Corrah

Pneumonia remains the leading cause of death in young children worldwide. Global pneumonia control depends on a good understanding of the aetiology of pneumonia. Percutaneous transthoracic aspiration culture is much more sensitive than blood culture in identifying the aetiological agents of pneumonia. However, the procedure is not widely practised because of lack of familiarity with it and concerns about potential adverse events. We review the diagnostic usefulness and safety of this procedure over 25 years of its use in research and routine practice at the UK Medical Research Council (MRC), The Gambia, and give a detailed description of the procedure itself. Published materials were identified from the MRCs publication database and systematic searches using the PubMed/Medline and Google search engines. Data from a current pneumonia aetiology study in the unit are included together with clinical experience of staff practising at the unit over the period covered in this review. A minimum of 500 lung aspirates were performed over the period of review. Lung aspiration produces a greater yield of diagnostic bacterial isolates than blood culture. It is especially valuable clinically when pathogens not covered by standard empirical antibiotic treatment, such as Mycobacterium tuberculosis and Staphylococcus aureus, are identified. There have been no deaths following the procedure in our setting and a low rate of other complications, all transient. Lung aspiration is currently the most sensitive method for diagnosing pneumonia in children. With appropriate training and precautions it can be safely used for routine diagnosis in suitable referral hospitals.Pneumonia remains the leading cause of death in young children worldwide. Global pneumonia control depends on a good understanding of the aetiology of pneumonia. Percutaneous transthoracic aspiration culture is much more sensitive than blood culture in identifying the aetiological agents of pneumonia. However, the procedure is not widely practised because of lack of familiarity with it and concerns about potential adverse events. We review the diagnostic usefulness and safety of this procedure over 25 years of its use in research and routine practice at the UK Medical Research Council (MRC), The Gambia, and give a detailed description of the procedure itself. Published materials were identified from the MRCs publication database and systematic searches using the PubMed/Medline and Google search engines. Data from a current pneumonia aetiology study in the unit are included together with clinical experience of staff practising at the unit over the period covered in this review. A minimum of 500 lung aspirates were performed over the period of review. Lung aspiration produces a greater yield of diagnostic bacterial isolates than blood culture. It is especially valuable clinically when pathogens not covered by standard empirical antibiotic treatment, such as Mycobacterium tuberculosis and Staphylococcus aureus, are identified. There have been no deaths following the procedure in our setting and a low rate of other complications, all transient. Lung aspiration is currently the most sensitive method for diagnosing pneumonia in children. With appropriate training and precautions it can be safely used for routine diagnosis in suitable referral hospitals.


Clinical Infectious Diseases | 2017

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study

Nicholas Fancourt; Maria Deloria Knoll; Henry C. Baggett; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Juliet O. Awori; Breanna Barger-Kamate; James Chipeta; Andrea N. DeLuca; Mahamadou Diallo; Amanda J. Driscoll; Bernard E. Ebruke; Melissa M. Higdon; Yasmin Jahan; Ruth A. Karron; Nasreen Mahomed; David P. Moore; Kamrun Nahar; Sathapana Naorat; Micah Silaba Ominde; Daniel E. Park; Christine Prosperi

Summary In the Pneumonia Etiology Research for Child Health study, abnormal chest radiographs (CXRs) in cases were associated with hypoxemia, crackles, tachypnea, and fever. Overall, 54% of CXRs were abnormal (site range, 35%–64%). Consolidation on CXR was associated with an increased risk of mortality.


Clinical Infectious Diseases | 2017

Standardized interpretation of chest radiographs in cases of pediatric pneumonia from the PERCH study

Nicholas Fancourt; Maria Deloria Knoll; Breanna Barger-Kamate; John de Campo; Margaret de Campo; Mahamadou Diallo; Bernard E. Ebruke; Daniel R. Feikin; Fergus V. Gleeson; Wenfeng Gong; Laura L. Hammitt; Rasa Izadnegahdar; Anchalee Kruatrachue; Shabir A. Madhi; Veronica Manduku; Fariha Bushra Matin; Nasreen Mahomed; David P. Moore; Musaku Mwenechanya; Kamrun Nahar; Claire Oluwalana; Micah Silaba Ominde; Christine Prosperi; Joyce Sande; Piyarat Suntarattiwong; Katherine L. O’Brien

Abstract Background. Chest radiographs (CXRs) are a valuable diagnostic tool in epidemiologic studies of pneumonia. The World Health Organization (WHO) methodology for the interpretation of pediatric CXRs has not been evaluated beyond its intended application as an endpoint measure for bacterial vaccine trials. Methods. The Pneumonia Etiology Research for Child Health (PERCH) study enrolled children aged 1–59 months hospitalized with WHO-defined severe and very severe pneumonia from 7 low- and middle-income countries. An interpretation process categorized each CXR into 1 of 5 conclusions: consolidation, other infiltrate, both consolidation and other infiltrate, normal, or uninterpretable. Two members of a 14-person reading panel, who had undertaken training and standardization in CXR interpretation, interpreted each CXR. Two members of an arbitration panel provided additional independent reviews of CXRs with discordant interpretations at the primary reading, blinded to previous reports. Further discordance was resolved with consensus discussion. Results. A total of 4172 CXRs were obtained from 4232 cases. Observed agreement for detecting consolidation (with or without other infiltrate) between primary readers was 78% (κ = 0.50) and between arbitrators was 84% (κ = 0.61); agreement for primary readers and arbitrators across 5 conclusion categories was 43.5% (κ = 0.25) and 48.5% (κ = 0.32), respectively. Disagreement was most frequent between conclusions of other infiltrate and normal for both the reading panel and the arbitration panel (32% and 30% of discordant CXRs, respectively). Conclusions. Agreement was similar to that of previous evaluations using the WHO methodology for detecting consolidation, but poor for other infiltrates despite attempts at a rigorous standardization process.


Clinical Infectious Diseases | 2017

Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study

Henry C. Baggett; Nora L. Watson; Maria Deloria Knoll; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Martin Antonio; Juliet O. Awori; Vicky L. Baillie; Andrea N. DeLuca; Amanda J. Driscoll; Julie Duncan; Bernard E. Ebruke; Doli Goswami; Melissa M. Higdon; Ruth A. Karron; David P. Moore; Susan C. Morpeth; Justin M. Mulindwa; Daniel E. Park; Wantana Paveenkittiporn; Barameht Piralam; Christine Prosperi

Upper airway pneumococcal colonization density among children hospitalized with World Health Organization–defined pneumonia was associated with microbiologically confirmed pneumococcal pneumonia (MCPP). The optimal colonization density threshold for discriminating MCPP from non-MCPP was ≥7 log10 copies/mL (sensitivity, 64.3%, specificity, 92.2%).

Collaboration


Dive into the Bernard E. Ebruke's collaboration.

Top Co-Authors

Avatar

Readon C. Ideh

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel E. Park

George Washington University

View shared research outputs
Top Co-Authors

Avatar

Daniel R. Feikin

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge